Back

Aspirin, not without bleeding risk in the real world: results of a UK cohort study evaluating the use of antiplatelet therapy for stroke prevention in atrial fibrillation (AF)

28 August 2016 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster session 3 - Anticoagulation in atrial fibrillation III Atrial fibrillation (AF) ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Essra Ridha

Bristol-Myers Squibb Pharmaceuticals Limited , London (United Kingdom of Great Britain & Northern Ireland)

24 More presentations in this session

Presentation thumbnail
Professor D. Xavier (Bangalore, IN)
Abstract Slides
Presentation thumbnail
Doctor C. Gatti (Ravenna, IT)
Abstract Slides
Presentation thumbnail
Doctor D. Iglesias (Santiago de Compostela, ES)
Abstract Slides
Presentation thumbnail
Doctor J. Wieczorek (Katowice, PL)
Abstract Slides
Presentation thumbnail
Associate Professor A. Parwani (Berlin, DE)

Access the full session

Session thumbnail
Poster session 3 - Anticoagulation in atrial fibrillation III

The Event

Event poster

ESC Congress 2016

28 August 2016 14:00 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources